Rhapsido Becomes First FDA-Approved Treatment for Hives Triggered by Scratching, but Fewer Than a Third Fully Cleared

The FDA approved Rhapsido for symptomatic dermographism, hives set off by scratching. In its trial, 29.3% fully cleared vs. 14.0% on placebo.

Have A Referral?